Sigma Capital Management’s MacroGenics MGNX Stock Holding History

Sigma Capital Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-50,000	Closed	-$1.39M	–	65
2014 Q1	$1.39M	Buy	+50,000	New	+$1.77M	0.07%	143

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

PCA

Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return

Sigma Capital Management's MGNX Position: Q2 2014 in Review

Sigma Capital Management sold out of MacroGenics (MGNX) in Q2 2014, closing a stake of 50,000 shares — an estimated $1.39M sold.

Sigma Capital Management first reported a position in MGNX in Q1 2014 and held it in 1 quarter. The position peaked at $1.39M in Q1 2014. 89 funds tracked by Wall St. Rank hold MGNX as of Q2 2014.

Sigma Capital Management reported no remaining MacroGenics position as of Q2 2014 after selling out during the quarter.
Sigma Capital Management sold 50,000 MacroGenics shares in Q2 2014, an estimated $1.39M.
Sigma Capital Management first reported a position in MacroGenics in Q1 2014 and held it in 1 quarter.
Sigma Capital Management's MacroGenics position peaked at $1.39M in Q1 2014.
89 funds tracked by Wall St. Rank held MacroGenics as of Q2 2014.

Based on Sigma Capital Management's 13F filing for Q2 2014.